Abbott boosts investment in NRF2 activators for reducing oxidative stressSarah CrunkhornNature Reviews Drug DiscoveryFebruary 1, 201210.1038/nrd3655Cited by 71Open AccessFull TextSaveCiteExport RISWatch citationsAbstractRelated PapersNo related papers foundPowered by citation graph analysis